The network, PEDSnet, combines big data from electronic health records with family engagement
A clinical research network that includes a pediatric researcher at The Children’s Hospital of Philadelphia (CHOP) has been granted $8.6 million for a 3-year period by the Patient-Centered Outcomes Research Institute.
The network, called PEDSnet, combines big data from electronic health records with family engagement—parents will be included in research design to address concerns that are important to families, especially those living with a chronically ill child.
"Families may have a different set of priorities than the researchers,” she added, “and identifying which outcomes are important to parents and children helps to shape how the research is conducted,” said Amy Kratchman, a family consultant at CHOP who is a part of the PEDSnet steering board.
Read more at newswise.
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More